Cancer treatment reviewsHumansAnti-Mullerian HormoneFemaleBreast NeoplasmsOvary
AMH as a marker for resumption of ovarian function after chemotherapy: an IPD meta-analysis and systematic review.
Charissa van Zwol-Janssens, Mandy van M Rosmalen, Joop S E Laven, Kazem Nasserinejad, Jenny A Visser, Richard A Anderson, Irit Ben-Aharon, Thomas Freour, Kathryn J Ruddy, H Irene Su, Yvonne V Louwers, Agnes Jager
Published: 202610.1016/j.ctrv.2025.103068
Abstract
BACKGROUND: In premenopausal women with breast cancer, chemotherapy often leads to amenorrhea that could be temporary or permanent. Anti-Müllerian hormone (AMH) is a potential biomarker predicting resumption of ovarian function, an outcome that aids…
Preview only. Read the full abstract at the source